Hormone receptor positive breast cancer represents the majority of breast cancer cases, and understanding this diagnosis opens the door to effective, targeted treatments that can significantly improve outcomes and quality of life for patients.

Understanding Treatment Options for Hormone Receptor Positive Breast Cancer

When someone receives a diagnosis of hormone receptor positive breast cancer, the main goal of treatment is to control the disease, reduce the risk of cancer coming back, and help patients maintain the best possible quality of life. Treatment decisions depend heavily on several factors, including the stage of the cancer when discovered, whether it has spread to other areas, the patient’s overall health, and their personal preferences.^[1]

This type of breast cancer is unique because the cancer cells have special proteins called hormone receptors on their surface. These receptors respond to hormones naturally present in the body—specifically estrogen and progesterone. When these hormones attach to the receptors, they send signals that cause the cancer cells to grow and multiply. This characteristic makes the cancer “hormone-sensitive,” meaning it depends on hormones to fuel its growth.^[2]

The good news is that because these cancers rely on hormones to grow, they can be treated with therapies specifically designed to block or reduce hormone activity in the body. Medical societies and cancer organizations have established standard treatment approaches that are proven to work. At the same time, researchers continue to explore new therapies through clinical trials, searching for even more effective ways to treat this disease and improve patient outcomes.^[3]

Most breast cancers fall into the hormone receptor positive category. Studies show that approximately 70 to 80 percent of breast cancers in women test positive for estrogen receptors, and many of these are also positive for progesterone receptors. Even in men, who can also develop breast cancer, about 90 percent of cases are estrogen receptor positive.^[2] This high percentage means that the majority of breast cancer patients are candidates for hormone-based treatments, which have been refined and improved over many decades of research.

Standard Treatment Approaches

The cornerstone of treating hormone receptor positive breast cancer is hormone therapy, also called endocrine therapy. This type of treatment works by either blocking the body’s ability to produce hormones or by interfering with how hormones affect breast cancer cells. It is fundamentally different from hormone replacement therapy used for menopause symptoms—in fact, it does the exact opposite. While hormone replacement therapy adds hormones to the body, hormone therapy for breast cancer blocks or reduces them.^[2]

There are several main types of hormone therapy used in standard treatment. The first category is called aromatase inhibitors. These drugs work by stopping an enzyme called aromatase from converting other hormones into estrogen. Common aromatase inhibitors include anastrozole, letrozole, and exemestane. These medications are particularly effective in postmenopausal women, whose ovaries have stopped producing estrogen but whose bodies still make small amounts through other tissues like fat and skin.^[10]

Another important category is selective estrogen receptor modulators, or SERMs. The most well-known drug in this group is tamoxifen. SERMs work by attaching to estrogen receptors on cancer cells, blocking estrogen from binding to them. Think of it like a key that fits into a lock but doesn’t turn it—the SERM occupies the receptor but doesn’t activate the cancer-promoting signals that estrogen would trigger. Tamoxifen can be used in both premenopausal and postmenopausal women.^[11]

A third type of hormone therapy is selective estrogen receptor downregulators, or SERDs. Fulvestrant is the main drug in this category. It not only blocks estrogen receptors but also causes the receptors to break down, reducing their number in cancer cells. This drug is typically given as an injection and is especially useful for advanced breast cancer or when other hormone therapies have stopped working.^[12]

For premenopausal women, whose ovaries are still actively producing estrogen, treatment may include suppressing ovarian function. This can be achieved in several ways. Surgery to remove the ovaries, called oophorectomy, is one permanent option. Radiation to the ovaries can also stop them from working. Alternatively, doctors may prescribe drugs called gonadotropin-releasing hormone agonists, or GnRH agonists, which temporarily suppress ovarian function. These medications work by interfering with the signals that tell the ovaries to produce hormones.^[10]

Hormone therapy is typically used in combination with other treatments. After surgery to remove the tumor, patients usually receive hormone therapy to reduce the risk of the cancer returning. This is called adjuvant therapy. If the tumor is large, hormone therapy might be given before surgery to shrink it, which is called neoadjuvant therapy. For cancer that has spread to other parts of the body, hormone therapy helps control growth and slow progression.^[3]

Clinical guidelines recommend that patients take hormone therapy for an extended period—typically five to ten years, depending on individual risk factors. Research has shown that taking tamoxifen for five years reduces the risk of cancer recurrence, and extending treatment to ten years provides even greater benefit. Similarly, aromatase inhibitors are often prescribed for five years or longer after initial treatment.^[12]

Surgery is usually part of the treatment plan as well. Options include lumpectomy, where only the tumor and a small amount of surrounding tissue are removed, or mastectomy, where the entire breast is removed. The choice depends on tumor size, location, and patient preference. Radiation therapy is often given after lumpectomy to destroy any remaining cancer cells in the breast area.^[9]

While chemotherapy is not always necessary for hormone receptor positive breast cancer, it may be recommended in certain situations—for example, if the tumor is large, has spread to lymph nodes, or shows other high-risk features. Chemotherapy uses drugs that kill rapidly dividing cells throughout the body.^[9]

Like all medical treatments, hormone therapy can cause side effects. The specific side effects depend on which type of hormone therapy is used and the individual patient. Common side effects include hot flashes similar to menopause symptoms, joint and muscle pain, bone thinning over time, vaginal dryness, and mood changes. Some patients also experience fatigue or difficulty concentrating, sometimes called “brain fog.” Weight gain and increased risk of blood clots can occur with certain medications.^[14]

Many of these side effects can be managed with additional medications or lifestyle changes. For example, certain antidepressants can help reduce hot flashes, lubricants can address vaginal dryness, and medications called bisphosphonates can prevent bone loss. Exercise and maintaining a healthy weight have been shown to help manage side effects and improve overall well-being during and after treatment.^[17]

Promising Treatments Being Tested in Clinical Trials

While standard hormone therapies are effective for many patients, some cancers develop resistance over time, meaning the treatments stop working. Additionally, some patients cannot tolerate the side effects of current therapies. This has led researchers to investigate new and innovative treatments through clinical trials. These studies test whether new drugs or combinations of drugs are safe and effective before they become widely available.^[5]

One exciting area of research involves drugs called cyclin-dependent kinase 4 and 6 inhibitors, often abbreviated as CDK4/6 inhibitors. These drugs work differently from traditional hormone therapy. CDK4 and CDK6 are proteins that help control how cells divide and grow. Cancer cells often have overactive versions of these proteins, causing them to multiply out of control. CDK4/6 inhibitors block these proteins, putting the brakes on cancer cell division. Palbociclib is one example of a CDK4/6 inhibitor that has been studied in clinical trials and is now approved for use in certain situations, typically in combination with hormone therapy for advanced breast cancer.^[12]

Another promising approach being studied is the use of drugs that target a protein called mammalian target of rapamycin, or mTOR. This protein plays a role in cell growth and survival. When hormone receptor positive breast cancer becomes resistant to hormone therapy, it sometimes happens because the mTOR pathway becomes overactive, allowing cancer cells to keep growing despite hormone blockade. Drugs that inhibit mTOR, used alongside hormone therapy, may help overcome this resistance.^[12]

Clinical trials are typically organized into phases. Phase I trials focus on safety—researchers want to know if a new treatment is safe enough to give to patients, what dose should be used, and what side effects might occur. These trials usually involve a small number of participants. Phase II trials test whether the treatment actually works—does it shrink tumors or slow cancer growth? These trials involve more patients. Phase III trials compare the new treatment to the current standard treatment to see if the new approach is better, and they involve large numbers of patients, sometimes hundreds or thousands.^[5]

Some trials are investigating combinations of hormone therapy with newer targeted drugs for patients whose cancer has features that make it resistant to standard treatment. For example, researchers are studying what happens when CDK4/6 inhibitors are added to aromatase inhibitors or fulvestrant. Early results from some of these studies have shown that the combinations can help patients whose cancer has stopped responding to hormone therapy alone.^[5]

Another area of investigation involves understanding the biological mechanisms that cause resistance to hormone therapy. Scientists have discovered that cancer cells can develop changes, or mutations, that allow them to grow without needing hormones. By identifying these mechanisms, researchers can develop drugs that specifically target the resistance pathways. This approach represents a more personalized form of cancer treatment, where therapy is tailored to the specific characteristics of each person’s cancer.^[5]

Clinical trials for hormone receptor positive breast cancer are conducted at cancer centers around the world, including in Europe, the United States, and many other countries. Patients who are interested in participating in a trial need to meet certain eligibility criteria, which vary depending on the specific study. Factors that determine eligibility might include the stage of cancer, previous treatments received, overall health status, and the specific characteristics of the tumor.^[5]

Participating in a clinical trial can give patients access to new treatments before they are widely available. However, it’s important to understand that experimental treatments may not work better than standard treatments, and they may have unexpected side effects. Patients considering a clinical trial should have detailed discussions with their healthcare team about the potential benefits and risks.^[5]

Most common treatment methods

• Hormone therapy (Endocrine therapy)
  • Aromatase inhibitors such as anastrozole, letrozole, and exemestane block the production of estrogen in the body by stopping the aromatase enzyme from working.
  • Selective estrogen receptor modulators like tamoxifen attach to estrogen receptors on cancer cells, preventing estrogen from binding and activating them.
  • Selective estrogen receptor downregulators such as fulvestrant not only block estrogen receptors but also cause them to break down, reducing their numbers in cancer cells.
  • Treatment typically continues for five to ten years to reduce the risk of cancer recurrence.
• Ovarian suppression
  • Used in premenopausal women to stop the ovaries from producing estrogen.
  • Can be achieved through surgery to remove the ovaries, radiation treatment, or medications called GnRH agonists that temporarily suppress ovarian function.
• Surgery
  • Lumpectomy removes the tumor and a small amount of surrounding tissue, preserving most of the breast.
  • Mastectomy removes the entire breast and is used for larger tumors or when multiple areas of cancer are present.
• Radiation therapy
  • Often given after lumpectomy to destroy any remaining cancer cells in the breast area.
  • Uses high-energy beams to target cancer cells while minimizing damage to healthy tissue.
• Chemotherapy
  • May be recommended for larger tumors, cancer that has spread to lymph nodes, or other high-risk features.
  • Uses drugs that kill rapidly dividing cells throughout the body.
• Targeted therapy
  • CDK4/6 inhibitors like palbociclib block proteins that help cancer cells divide and grow.
  • Often used in combination with hormone therapy for advanced or metastatic breast cancer.

Lifestyle Changes That Support Treatment

While medical treatments are the primary way to fight hormone receptor positive breast cancer, research has shown that certain lifestyle changes can support treatment effectiveness and improve overall health outcomes. These modifications don’t replace medical treatment but work alongside it to give patients the best possible chance of staying healthy.^[16]

Maintaining a healthy body weight is one of the most important lifestyle factors. Studies have consistently shown that women who are overweight or obese at the time of diagnosis, or who gain significant weight during treatment, have a higher risk of cancer recurrence and breast cancer-related death. Extra body weight can increase levels of estrogen and other hormones in the body, which may fuel the growth of hormone receptor positive cancer cells. Experts recommend maintaining a healthy weight through balanced eating and regular physical activity.^[16]

Physical activity has multiple benefits for breast cancer patients. Regular exercise can help manage treatment side effects like fatigue, improve mood and mental health, maintain bone strength, and reduce the risk of cancer recurrence. Research suggests that even moderate activity, such as walking for thirty minutes most days of the week, can make a meaningful difference. More vigorous exercise like running, swimming, or cycling may provide additional benefits. The key is finding activities that fit individual fitness levels and preferences.^[17]

Diet also plays a role in supporting health during and after breast cancer treatment. While no specific food can cure cancer, eating a balanced diet rich in vegetables, fruits, whole grains, and lean proteins supports overall health and may help reduce recurrence risk. Experts recommend limiting processed foods, red meat, and foods high in saturated fat. Increasing fiber intake through whole grains, legumes, vegetables, and fruits may be particularly beneficial.^[18]

Alcohol consumption is another factor to consider. Research has linked alcohol intake to increased breast cancer risk, and some evidence suggests it may also affect recurrence risk. Many cancer organizations recommend limiting alcohol or avoiding it entirely. If you choose to drink, keeping intake low—no more than one drink per day—is advisable.^[18]

Smoking is harmful for everyone, but it’s especially important for cancer patients to quit. Smoking can interfere with treatment effectiveness, slow healing after surgery, and increase the risk of other health problems. Support programs and medications are available to help people quit smoking successfully.^[16]

Managing stress and emotional well-being is also crucial. A cancer diagnosis brings significant psychological challenges, including anxiety, fear, and depression. Support from family and friends is important, but professional help may also be beneficial. Options include individual counseling, support groups where patients can connect with others facing similar challenges, and mind-body practices like meditation, yoga, or tai chi. These approaches can help reduce anxiety, improve sleep, and enhance overall quality of life.^[14]

Some patients are interested in complementary approaches like acupuncture. Research suggests that acupuncture may help manage certain side effects of cancer treatment, including hot flashes, joint pain, and nausea. It’s important to work with qualified practitioners and to inform your cancer care team about any complementary therapies you’re using.^[17]

Patients should be cautious about dietary supplements, vitamins, herbal products, and other non-regulated “health” products. While some supplements may seem harmless, they can actually interfere with cancer treatments or cause unexpected side effects. Always discuss any supplements or herbal remedies with your healthcare team before using them.^[17]